| Publisher |
Royal Society of Chemistry |
| Agreement ID | rsc2025xmu |
| Agreement labeling | RSC P&R |
| Has the agreement been disclosed and published? | No |
| Agreement period | 01/01/2025 – 12/31/2025 |
| Consortia / Institution | Xiamen University Libraries |
| Country | China |
| SIZE
Approximate range of annual corresponding author publications |
21 |
| Comments on size/article output | About one third of the total annual publication |
| COSTS
How do the costs of the agreement relate to previous subscription-only agreements with the publisher? |
Agreement costs within the range of the previous spending level |
| FINANCIAL SHIFT
Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard? |
Subscriptions partly converted to OA publishing fees |
| RISK SHARING
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements? |
Vouchers that have not been used up can be extended to the second year. The range of APC adjustments during the agreement period is also striking. |
| OA COVERAGE
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement? |
No |
| Are fully open access journals covered by the agreement? | No |
| OA LICENSE | CC-BY or CC-BY-NC |
| ARTICLE TYPES |
Original research articles Review articles Proceedings |
| ACCESS COSTS
What is the approximate share of access related costs of the overall agreement? |
0% |
| ACCESS COVERAGE
Are all read relevant journals covered by the agreement? |
Yes |
| PERPETUAL ACCESS RIGHTS | Yes |
| WORKFLOW ASSESSMENT | Ok |
| OVERALL ASSESSMENT AND COMMENTS | APCs in excess of the quota enjoy a 15% discount |
| Request contact to the licensee | contact@esac-initiative.org |